Pliant Therapeutics, Inc.
PLRX
$1.48
$0.010.68%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 1.87% | -5.07% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -14.02% | 2.27% | |||
| Operating Income | 14.02% | -2.27% | |||
| Income Before Tax | 13.90% | -3.42% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 13.90% | -3.42% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 13.90% | -3.42% | |||
| EBIT | 14.02% | -2.27% | |||
| EBITDA | 14.02% | -2.44% | |||
| EPS Basic | 14.08% | -2.82% | |||
| Normalized Basic EPS | 14.08% | -2.84% | |||
| EPS Diluted | 14.08% | -2.82% | |||
| Normalized Diluted EPS | 14.08% | -2.84% | |||
| Average Basic Shares Outstanding | 0.20% | 0.58% | |||
| Average Diluted Shares Outstanding | 0.20% | 0.58% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||